Dr Reddy's Laboratories

The Trump effect: How Indian pharma’s ‘beyond US’ bet is finally paying off

Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs on…

November 11, 2025 05:30 IST

10 stocks with up to 22% upside – Top brokerage Buys this week

Discover 10 top brokerage stock picks with up to 22% upside this week—see which shares could boost your portfolio now!

November 1, 2025 08:00 IST

Dr Reddy’s Laboratories reported a 6.36 per cent YoY profit growth in the second quarter

Dr Reddy’s Q2 FY26 profit rises 6% YoY to Rs 1,426 crore; revenue up 9%

Dr Reddy’s Q2 FY26 profit rises 6% YoY to ₹1,426 crore; revenue up 9% to Rs 8,805 crore, but margins…

October 24, 2025 17:32 IST

From Infosys, Tata Motors to LTIMindtree, Punjab National Bank – Here are 11 stocks to watch today

Track top stocks like Infosys, Tata Motors, LTIMindtree, PNB, and more as Dalal Street opens for an eventful trading day—see…

October 23, 2025 06:30 IST

From Vedanta, Adani Power to RailTel, Aditya Birla Capital – Here are 11 stocks to watch today

Track key stocks like Vedanta, Adani Power, RailTel, and Aditya Birla Capital as major announcements drive market action today—see the…

September 15, 2025 06:30 IST

Trump’s tariff threats are spooking pharma. Are MNC stocks the answer?

Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…

August 19, 2025 15:49 IST

Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential

Growth prescription: The future is specialty; Sun Pharma, Dr Reddy’s, Cipla lead, says Nomura

Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…

August 11, 2025 16:58 IST

Dr Reddy's Q1 results 2025, Dr Reddy's earnings Q1FY25, Dr Reddy's profit and revenue Q1, Dr Reddy's quarterly results July 2025, Dr Reddy's share price after Q1 results, Dr Reddy's financial performance Q1FY25, Indian pharma earnings Q1FY25, and Dr Reddy's stock news today

Dr Reddy’s Q1FY26: Profit below estimates; revenue up 11.4%- Key 5 takeaways

Dr Reddy’s Q1FY26: Profit below estimates at 1.26%; revenue up 11.4%.

Updated: July 23, 2025 18:55 IST

The big movers in trade today: A look at top 5 gainers on Nifty

Zomato leads Nifty gainers with a 5% rally; explore full list of top market movers now!

June 5, 2025 16:51 IST

Dr Reddy’s Laboratories, cancer drug, Keytruda, partnership, Alvotech, biosimilar, license agreement, manufacturing

Dr Reddy’s, Alvotech partner to develop and commercialize biosimilar of cancer drug Keytruda

Dr Reddy’s Laboratories announced that it has partnered with Alvotech, to co-develop, manufacture, and sell a biosimilar version of Keytruda…

Updated: June 5, 2025 10:29 IST

From Vodafone Idea, BEL, Divi’s Lab to Premier Energies- Here are 8 stocks to watch

Stocks to watch today, May 19: GIFT Nifty indicates a positive start for domestic indices. Here are top stocks to…

May 19, 2025 06:25 IST

Dr Reddy’s Q4 Results: Profit rises by 21% to Rs 1,587 crore on strong sales

Dr Reddy’s posted consolidated net profit growth of 21 per cent year-on-year to Rs 1,587 crore during the March quarter,…

May 9, 2025 18:27 IST

Why are pharma stocks down today? Here’s why Trump’s executive orders spark sell-off

The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active and faster…

Updated: May 6, 2025 12:47 IST

Nifty Pharma Index, BSE Healthcare Index, pharma stocks today

Nomura’s top pharma bets include Dr. Reddy’s, Cipla, Lupin and Zydus

Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends!

May 2, 2025 16:05 IST

Nifty 200-day SMA, FIIs short positions, HDFC Bank, Reliance Industries

Stocks to watch: From Macrotech Developers, Vedanta to Reliance Industries, Here’s a list of 10 stocks in news today

Stocks to watch today, April 15: Explore the latest stock alerts: Macrotech, Reliance, Vedanta, Dr Reddy’s, and more. Check out…

April 15, 2025 06:33 IST

Dr Reddy’s may cut workforce by 25%, including those in Rs 1 crore bracket: Report

Dr Reddy’s may cut 25% of its workforce, including high earners, amid cost-cutting. Learn more!

Updated: April 14, 2025 20:12 IST

Three reasons why pharma stocks are falling today?

Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

Updated: March 25, 2025 14:45 IST

Boehringer Ingelheim, Boehringer Ingelheim India, Boehringer Ingelheim diabetes, Empagliflozin, Empagliflozin in India, patent loss, healthcare news pharma news,

Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India?

Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.

March 11, 2025 10:51 IST

Related News

An incorrect name on your Aadhaar can lead to severe issues with KYC (Know Your Customer) compliance, bank accounts, and benefits distribution.

Aadhaar card online update: How to change name, address, date of birth and phone number online in simple steps

Forget Rs 1 crore: Why Rs 50 lakh is the only number that matters for financial freedom

e-Passport launches in India: Check eligibility, how to apply, application fee, benefits, key security upgrades and more

Govt cuts gratuity eligibility to 1 year from 5 under new Labour Codes

Govt cuts gratuity eligibility to 1 year from 5 years under new Labour Codes

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

Luggage to flaunt: Offering smart features like USB ports, anti-theft zippers, and more

Lifestyle34 min ago

The Indian luggage industry is evolving with a focus on innovation and catering to the demands of millennials and Gen Z. Water-repellent, anti-theft, and tech-savvy luggage are in high demand due to rising disposable incomes and travel habits. Digital-first disruptors and legacy brands are both embracing product innovation and influencer partnerships.

View all shorts